CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions - PubMed (original) (raw)
Review
CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions
G D Ross et al. Clin Exp Immunol. 1993 May.
Abstract
The C3 receptor CR3 is expressed on phagocytic cells, minor subsets of B and T cells, and natural killer (NK) cells. It has important functions both as an adhesion molecule and a membrane receptor mediating recognition of diverse ligands such as intercellular adhesion molecule-1 (ICAM-1) and fixed iC3b. The receptor is capable of undergoing an activation event that regulates both its specificity for various ligands and its ability to mediate phagocytosis or extracellular cytotoxicity. Certain bacteria express carbohydrates or lipopolysaccharides (LPS) that can bind to and activate CR3, allowing the receptor to assume its activated state. Soluble beta-glucan derived from the yeast Saccharomyces cerevisiae is a particularly potent stimulator of CR3, and produces an activated state of the receptor that permits neutrophil phagocytosis of iC3b-coated erythrocytes or NK, cell cytotoxicity of iC3b-coated tumour cells, that are normally resistant to NK cells.
Similar articles
- Contribution of CR3, CD11b/CD18 to cytolysis by human NK cells.
Klein E, Di Renzo L, Yefenof E. Klein E, et al. Mol Immunol. 1990 Dec;27(12):1343-7. doi: 10.1016/0161-5890(90)90041-w. Mol Immunol. 1990. PMID: 1980339 Review.
Cited by
- Multiple lupus-associated ITGAM variants alter Mac-1 functions on neutrophils.
Zhou Y, Wu J, Kucik DF, White NB, Redden DT, Szalai AJ, Bullard DC, Edberg JC. Zhou Y, et al. Arthritis Rheum. 2013 Nov;65(11):2907-16. doi: 10.1002/art.38117. Arthritis Rheum. 2013. PMID: 23918739 Free PMC article. - Effects of adacolumn selective leukocytapheresis on plasma cytokines during active disease in patients with active ulcerative colitis.
Hanai H, Iida T, Yamada M, Sato Y, Takeuchi K, Tanaka T, Kondo K, Kikuyama M, Maruyama Y, Iwaoka Y, Nakamura A, Hirayama K, Saniabadi AR, Watanabe F. Hanai H, et al. World J Gastroenterol. 2006 Jun 7;12(21):3393-9. doi: 10.3748/wjg.v12.i21.3393. World J Gastroenterol. 2006. PMID: 16733857 Free PMC article. Clinical Trial. - From Cancer Therapy to Winemaking: The Molecular Structure and Applications of β-Glucans and β-1, 3-Glucanases.
Caseiro C, Dias JNR, de Andrade Fontes CMG, Bule P. Caseiro C, et al. Int J Mol Sci. 2022 Mar 15;23(6):3156. doi: 10.3390/ijms23063156. Int J Mol Sci. 2022. PMID: 35328577 Free PMC article. Review. - Murine Macrophage Requires CD11b to Recognize Talaromyces marneffei.
Hu Y, Lu S, Xi L. Hu Y, et al. Infect Drug Resist. 2020 Mar 27;13:911-920. doi: 10.2147/IDR.S237401. eCollection 2020. Infect Drug Resist. 2020. PMID: 32273736 Free PMC article. - Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson's disease.
Sanchez-Guajardo V, Febbraro F, Kirik D, Romero-Ramos M. Sanchez-Guajardo V, et al. PLoS One. 2010 Jan 20;5(1):e8784. doi: 10.1371/journal.pone.0008784. PLoS One. 2010. PMID: 20098715 Free PMC article.
References
- J Immunol. 1991 May 15;146(10):3557-62 - PubMed
- Mol Immunol. 1990 Dec;27(12):1343-7 - PubMed
- Infect Immun. 1991 Aug;59(8):2573-8 - PubMed
- Pediatr Res. 1991 Jul;30(1):118-23 - PubMed
- Infect Immun. 1991 Dec;59(12):4524-30 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous